Quantification of pro-B-type natriuretic peptide and its products in human plasma by use of an analysis independent of precursor processing

Keyphrases

• B-type Natriuretic Peptide 100%
• Precursor Processing 100%
• Human Plasma 100%
• Healthy Individuals 18%
• Healthy Volunteers 9%
• Plasma Concentration 9%
• Cardiac Disease 9%
• Peptide Concentration 9%
• Highly Sensitive 9%
• Patients with Heart Failure 9%
• Heart Failure Patients 9%
• Heart Disease Diagnosis 9%
• Age-matched 9%
• Derived Peptide 9%
• Cardiac Natriuretic Peptides 9%
• Processing-independent Analysis 9%
• Preanalytical Phase 9%
• Trypsin 9%
• Antiserum 9%
• Epitope 9%
• Binding Affinity 9%
• Plasma Proteins 9%
• High Titer 9%
• Discrepant Results 9%
• Total Concentration 9%
• Enzymatic Treatment 9%
• Peptide Processing 9%

Neuroscience

• Brain Natriuretic Peptide 100%
• Amino Terminal Sequence 20%
• Posttranslational Modification 10%
• Binding Affinity 10%
• Antiserum 10%
• Epitope 10%
• Natriuretic Peptide 10%
• Antibodies 10%